中东和非洲放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型（外束放射治疗和内束放射治疗）和应用（乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等）
放射肿瘤学技术进步促进中东和非洲放射肿瘤学市场发展
放射治疗专注于摧毁癌细胞，最大限度地保留健康细胞，这是随着时间的推移由于磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等成像技术的进步而实现的。这些成像技术有助于识别肿瘤细胞及其确切位置和大小，从而促进了 3D 适形放射治疗的发展。随着时间的推移，放射治疗技术不断发展，如下所述
Flash 治疗：医疗专业人士正在讨论这项技术，它不需要几天或几周的时间，而是一次性快速地输送大量辐射。健康细胞会在一段时间内恢复良好，并且只杀死癌细胞。它正在研究中，如果证明其安全有效，它可能在未来几年成为革命性的放射治疗方法。
图像引导放射治疗 (IGRT)：该技术可在每次治疗前对肿瘤和周围健康组织进行实时成像，确保辐射束准确瞄准肿瘤并最大限度地减少对附近器官的损害。
调强放射治疗 (IMRT)：IMRT 可将不同强度的辐射输送到肿瘤的不同部位，从而实现更好的剂量分布并保护健康组织。
立体定向放射治疗 (SBRT)：该技术在有限次数的治疗中向小而边界清晰的肿瘤发射高剂量的辐射，从而更好地对肿瘤进行局部控制。
质子治疗：质子治疗使用质子代替传统 X 射线向肿瘤发射辐射，从而可以更精确地瞄准肿瘤并保护健康组织。
自适应放射治疗：该技术可以根据治疗过程中肿瘤大小或位置的变化调整治疗计划，确保始终优化辐射剂量以实现最大疗效。
此外，人工智能 (AI) 在癌症治疗中的整合度不断提高，用于治疗计划、标记解剖患者 CT 扫描图像等。AI 将通过在治疗过程中提供所需的解决方案来帮助即时满足患者的需求。此外，各种放射治疗设备都与 AI 集成，这将使患者和医疗保健专业人员都受益。例如，2024 年 5 月，Elekta 推出了其最新的直线加速器 (linac) Evo，这是一款具有新型高清 AI 增强成像的 CT-Linac，能够提供离线和在线自适应放射治疗以及改进的标准图像引导放射治疗。因此，放射治疗技术的发展和人工智能的日益融合预计将在未来几年加速放射肿瘤学市场的增长。
中东和非洲放射肿瘤学市场概览
在过去的 50 年里，沙特阿拉伯通过几项重大成就在海湾地区开创了癌症护理服务。各个癌症治疗领域的进展与其 2030 愿景相一致。目前，沙特阿拉伯有约 60 名有执照的放射肿瘤学家或临床肿瘤学家为患者提供放射治疗。利雅得法赫德国王医疗城的沙特质子治疗中心成为该国和阿拉伯世界首个质子治疗机构。沙特发展基金 (SFD) 于 2021 年 7 月在约旦北部城市拉姆萨的阿卜杜拉国王大学医院开设了沙特癌症患者放射治疗中心。该中心每年通过提供基本服务和加强约旦北部的医疗保健，帮助超过 1,200 名癌症患者。
中东和非洲放射肿瘤学市场收入和预测到 2031 年（百万美元）
中东和非洲放射肿瘤学市场细分
中东和非洲放射肿瘤学市场分为类型、应用和国家。
根据类型，中东和非洲放射肿瘤学市场分为外束放射治疗和内束放射治疗。 2023 年，外束放射治疗领域占有更大的市场份额。
在应用方面，中东和非洲放射肿瘤学市场细分为乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等。乳腺癌领域在 2023 年占有最大的市场份额。
按国家/地区划分，中东和非洲放射肿瘤学市场细分为沙特阿拉伯、南非、阿联酋和中东和非洲其他地区。2023 年，中东和非洲其他地区占据了中东和非洲放射肿瘤学市场份额的主导地位。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Perspective Therapeutics Inc、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcar、Panacea Medical Technologies Pvt。 Ltd 和 Curium 是中东和非洲放射肿瘤学市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Middle East & Africa Radiation Oncology Market - Key Market Dynamics
4.1 Market Drivers:
4.1.1 Increasing Prevalence of Cancer
4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Middle East & Africa Market Analysis
5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Radiation Oncology Market Analysis - by Types
6.1 External Beam Radiation Therapy
6.1.1 Overview
6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
6.2.1 Overview
6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Middle East & Africa Radiation Oncology Market Analysis - by Application
7.1 Breast Cancer
7.1.1 Overview
7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
7.2.1 Overview
7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
7.3.1 Overview
7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
7.4.1 Overview
7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
7.5.1 Overview
7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Radiation Oncology Market - Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
8.1.1.1 Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
8.1.1.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
8.1.1.2 South Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
8.1.1.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
8.1.1.3 United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
8.1.1.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
8.1.1.4 Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by Types
8.1.1.4.2 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.4.3 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.4.4 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by Application
9. Radiation Oncology Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Varian Medical Systems Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview (Siemens Healthineers AG)
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elekta AB
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Accuray Incorporated
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Becton Dickinson and Co
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Perspective Therapeutics Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Nordion
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Mevion Medical Systems
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 NTP RADIOISOTOPES
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Mallinckrodt Plc
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Provision Healthcare
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 Panacea Medical Technologies Pvt. Ltd
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Curium
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Radiation Oncology Market Segmentation
Table 2. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. Recent Organic Growth Strategies in Radiation Oncology Market
Table 19. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 20. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Middle East & Africa Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Middle East & Africa Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Middle East & Africa: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Perspective Therapeutics Inc
- Nordion
- Mevion Medical Systems
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Provision Healthcare
- Panacea Medical Technologies Pvt. Ltd
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.